Leverages clinical whole-genome sequencing and machine learning bioinformatics to deliver hereditary disease and personalized drug-response insights for healthcare networks.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
MyOme develops a clinical genomics platform and advanced bioinformatics software designed to deliver lifetime, actionable health insights from a single DNA sample. The company utilizes whole-genome sequencing combined with machine learning to generate comprehensive diagnostic and proactive screening profiles, crossing single-gene hereditary data with polygenic risk scores that account for diverse multi-ancestry backgrounds and lifestyle factors.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
MyOme Management Team
Investors
Foresite Capital
Founders Fund
HealthCare Ventures LLC
Sequoia
Softbank Capital
MyOme Valuations & Financials
View real-time NPM data on MyOme stock including daily MyOme stock price estimates, valuation history, and historical share price information. Access MyOme financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track MyOme pricing across six independent market signals. Looking for private company due diligence data sources on MyOme? Get in touch to learn more.
Similar Companies
like MyOme
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Cloudbeds
Commerce & Marketplaces
Platform that enables lodging operators to manage reservations, distribution, operations, and guest engagement seamlessly.
Biograph
Delivers advanced preventive health assessments using deep diagnostics and expert guidance to detect risks early and optimize long-term health.
ProGro Bio
Climate & Sustainability
Develops an organic microbial soil inoculant that enhances soil health and boosts crop yields through improved nutrient uptake and root development.
Alio
Leverages advanced AI to deliver real-time healthcare monitoring and insights, supporting better patient care and outcomes.
MariaDB
Enterprise Software
Deliver open-source database solutions that ensure compatibility with MySQL, offering scalability and reliability for diverse applications.
YellowBird
Connects businesses with certified safety professionals for incident investigations, audits, training, and on-site safety management.
Flashback
Healthcare & Life Sciences
Develops a machine learning platform that analyzes physiological data to support clinical decision-making in trauma and critical care environments.
EduMe
Mobile training platform providing deskless workers with seamless access to relevant knowledge, enabling workforce success.
FAQ
We have answers
MyOme stock does not trade on public stock exchanges. MyOme stock is considered a private security and you need to be an accredited investor to trade shares. To invest in MyOme stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
MyOme Stock does not trade on public stock exchanges. In order to sell MyOme shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
MyOme does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view MyOme share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for MyOme stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell MyOme stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in MyOme stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
MyOme is a private company and has not had an IPO. There is currently no MyOme IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to MyOme IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
